Pricing Log in Create free account

Neurogene Inc. (NGNE) vs SL SCIENCE HLDG (SLBT)

Neurogene Inc. and SL SCIENCE HLDG are both Biotechnology companies. Neurogene Inc. and SL SCIENCE HLDG are of similar size ($513.3M and $504.7M). Across the 1 metrics below, Neurogene Inc. leads on 1 and SL SCIENCE HLDG on 0.

Valuation

Metric NGNE SLBT Biotechnology median
P/E n/m — 10.60
P/S n/m — 9.40
P/B 2.63 n/m 2.13
Price to free cash flow n/m — 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (19.89%) — (32.88%)
Free cash flow yield (15.38%) — (23.13%)

Profitability

Metric NGNE SLBT Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% — 0.00%
Return on equity (45.32%) — (51.96%)
Return on assets (41.02%) — (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NGNE SLBT Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 0.93% — 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric NGNE SLBT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.64 4.44 4.97
Net debt to EBITDA 2.57 — 1.01

Dividend

Metric NGNE SLBT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NGNE SLBT Biotechnology median
Market cap 513.29m 504.74m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack